Comparison of two methods to detect P-glycoprotein in patients with chronic lymphocytic leukaemia

Clinical and Laboratory Haematology

Volumn 18, Issue 2, 1996, Pages 99-104

  Chin Yee, I ^a,b   Alshammari, S ^a   Anderson, L ^a   Kadri, M ^a   Keeney, M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

4E3; chronic lymphocytic leukaemia; daunorubicin; flow cytometry; P glycoprotein

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; EPITOPE; GLYCOPROTEIN P; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4E3; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG UPTAKE; FLOW CYTOMETRY; FLUORESCENCE; HISTOGRAM; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0029744357     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1996.00146.x     Document Type: Article

References (33)

1. Arceci R.J., Stieglitz K., Bras J. et al. (1993) Monoclonal antibody to an external epitope of the human mdr 1 P-glycoprotein. Cancer Research, 53, 310-317.
2. Baer M.R. & Bloomfield C.D. (1991) Multidrug resistance in acute myeloid leukemia. Journal of the National Cancer Institute, 83, 663-665.
3. Bradley G., Juranka F.F. & Ling V. (1988) Mechanism of multidrug resistance. Biochim Biophys Acta, 948, 87-128.
4. Bradley G., Sharma R., Rajalakshmi S. et al. (1992) P-glycoprotein expression during tumour progression in the rat liver. Cancer Research, 52, 5154-5161.
5. Campos L., Guyotat D., Archimbaud E. et al. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79, 473-476.
6. Campos L., Guyotat D., Jaffar C., Solary E., Archimbaud E. & Treille D. (1992) Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia. European Journal of Haematology, 48, 254-258.
7. Chin K.V., Ueda K., Pastan I. et al. (1992) Modulation of activity of the promoter of the human mdr1 gene by Ras and p53. Science, 255, 459-462.
8. Chin-Yee I., Crowther M.A., Keeney M., Wright L. & Daly S. (1994) Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines. Clinical and Laboratory Haematology, 16, 261-272.
9. Cole S.P.C., Bhardwaj G., Gerlach J.H. et al. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654.
10. Cumber P., Jacobs A., Hoy T. et al. (1990) Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia. British Journal of Haematology, 76, 226-230.
11. Cumber P.M., Jacobs A., Hoy T., Whittaker J.A., Tsuruo T. & Padua R.A. (1991) Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of p-glycoprotein. Leukemia. 5, 1050-1053.
12. Endicott J.A. & Ling V. (1989) The biochemistry of p-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry. 58, 137-171.
13. Hamada H. & Tsuruo T. (1986) Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proceedings of the National Academy of Science, 83, 7785-7789.
14. Hedley D.W. (1993) Assays of cancer chemotherapy resistance. In Handbook of Flow Cytometry Methods (ed. J.P. Robinson). Wiley-Liss, New York.
15. Herweijer H., Van Den Engh G. & Nooter K. (1989) A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells. Cytometry, 10, 463-468.
16. Herzog C.E., Trepel J.B., Mickley L.A., Bates S.E. & Fojo A.T. (1992) Various methods of analysis of mdr-1/p-glycoprotein in human colon cancer cell lines. Journal of the National Cancer Institute, 84, 711-716.
17. Holmes J.A., Jacobs A., Carter G., Whitaker J.A., Bentley D.P. & Padua R.A. (1990) Is the mdr1 gene relevent in chronic lymphocytic leukemia? Leukemia, 4, 216-218.
18. International Workshop on Chronic Lymphocytic Leukemia (1989) Chronic lymphocytic leukemia: recommendations for diagnosis. staging, and response criteria. Annals of Internal Medicine, 110, 236-238.
19. Klimecki W.T., Futscher B.W., Grogan T.M. & Dalton W.S. (1994) P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood, 83, 2451-2458.
20. Krishan A. (1987) Effect of drug efflux blockers on vital staining of cellular DNA with Hoechst 33342. Cytometry, 8, 642-645.
21. Krishan A. (1990) Rapid determination of cellular resistance-related drug efflux in tumor cells. Methods in Cellular Biology, 33, 491-500.
22. Ludescher C., Gattinger D.J., Hofmann J. & Grunicke H. (1991) rapid functional assay for the detection of multidrug-resistant cells using the fluorescent dye rhodamine-123. Blood, 78, 1385-1387.
23. Marie J.P., Zittoun R. & Sikic B.L. (1991) Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood, 78, 586.
24. Michieli M., Raspadori D., Damiani D. et al. (1991) The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 77, 460-465.
25. Muller C., Megetto F., Fillola G. et al. (1994) Daunorubicin accumulation and retention in fresh human myeloma cells: absence of correlation with P-glycoprotein expression. Blood, 84(10 Suppl. 1), 176a.
26. Nooter K. & Herweijer H. (1991) Multidrug resistance (mdr) genes in human cancer. British Journal of Cancer, 63, 663.
27. Pastan I. & Gottesman M. (1987) Multiple-drug resistance in human cancer. New England Journal of Medicine, 316, 1388-1393.
28. Pirker R., Wallner J., Geissner K. et al. (1991) MDR1 gene expression and treatment outcome in acute myeloid leukemia. Journal of the National Cancer Institute. 83, 708-712.
29. Rai K. (1987) A critical analysis of staging in CLL. In Chronic Lymphocytic Leukemia: Recent Progress and Future Directions. (Gale R.P. & Rai K. eds) Liss, New York.
30. Schneider J., Rubio M.P., Barbazán M.J. et al. (1994) P-glycoprotein. HER-2/neu. and mutant p53 expression in human gynecologic tumors. Journal of the National Cancer Institute Report. 86, 850-854.
31. Wall D.M., Hu X.F., Zalcberg J.R. & Parkin J.D. (1991) Rapid functional assay for multidrug resistance in human tumor cell lines using the fluorescent indicator fluo-3. Journal of the National Cancer Institute. 83, 206-207.
32. Wall D.M., Sparrow R., Hu X.F. et al. (1993) Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo- 3, European Journal of Cancer, 29A, 1024-1027.
33. Weinstein R.S., Jakate S.M., Dominguez J.M. et al. (1991) Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph nodes metastasis. Cancer Research, 51, 2720-2726.